Lonza
Dario Sannino is a seasoned professional in quality management and compliance within the pharmaceutical and biotechnology sectors. Currently serving as the Global Quality Compliance & Audit Management Director at Lonza since April 2021, Sannino focuses on minimizing quality risk through audits and enhancing compliance at various sites. Previous roles include Head of Quality Management at Lonza, Lead Auditor at GXP Consulting, and Corporate Quality Sr. Manager at Bracco. Sannino has extensive experience in managing quality systems, notably in cell and gene therapy environments, and has held significant positions at Baxter International and Merck Group, emphasizing auditing and quality assurance. Sannino holds a degree in Scienza e Ingegneria dei Materiali from Università degli Studi di Milano-Bicocca and has a background in laboratory techniques from IPSIA Ettore Maiorana.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.